Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov-Dec;21(6):394-396.
doi: 10.1016/j.ipej.2021.06.004. Epub 2021 Jun 22.

Successful termination of ventricular tachycardia with intrinsic anti-tachycardia pacing

Affiliations

Successful termination of ventricular tachycardia with intrinsic anti-tachycardia pacing

Itsuro Morishima et al. Indian Pacing Electrophysiol J. 2021 Nov-Dec.

Abstract

Intrinsic anti-tachycardia pacing (iATP) is a novel automated ATP algorithm that employs post-pacing interval (PPI) to design the next ATP sequence based on an analysis of the prior failed ATP sequence. A patient with hypertrophic cardiomyopathy received an implantable cardioverter-defibrillator (ICD) (Cobalt™ XT DR, Medtronic, Minneapolis, MN, USA) following an episode of syncope due to macro-reentrant ventricular tachycardia (VT) (right bundle branch block configuration, cycle length [CL] 280 ms). The VF zone was set to VTCL <300 ms and iATP therapy was prescribed before and during capacitor charging. The iATP was initiated when VT recurred 3 months later. The first attempt with an assumption of 150 ms propagation time from the pacing site to the VT circuit (9 pulses) could not reset the VT, leaving a PPI of 650 ms. A subsequent attempt involving 20 pulses with an assumption of 250 ms propagation time terminated the VT. Failure to reach the circuit is a major cause of unsuccessful ATP. In this regard, iATP is expected to have theoretical advantages over empirical and traditional ATP therapies. To the best of our knowledge, this is the first intracardiac electrogram illustrating how automated precision ATP terminates VT in a clinical setting.

Keywords: Implantable cardioverter-defibrillator; Intrinsic anti-tachycardia pacing; Ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Declaration of comepting interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Stored electrocardiogram of the event leading to ventricular tachycardia termination by the second intrinsic anti-tachycardia pacing (iATP) sequence.
Fig. 2
Fig. 2
Resetting (A) and no resetting (B) of ventricular tachycardia (VT) by the initial iATP sequence (TP). A. If the myocardial propagation time (PT) were within a default assumption of 150 ms propagation time, the VT resetting would be observed with nine ATP pulses, and the post pacing interval (PPI) would be within PT x 2 + VT cycle length (CL) (=580 ms). B. The long PPI indicates no resetting of the VT and the myocardial PT longer than 150 ms. Suppose the myocardial PT is 225 ms and the final iATP pulse collides with the VT wavefront 40 ms outside the VT circuit, the PPI would theoretically turn out to be 650 ms. TS, sensed tachycardia; VS, sensed V wave.

References

    1. Yee R., Fisher J.D., Birgersdotter-Green U. Initial experience with a new automated antitachycardia pacing algorithm: feasibility and safety in an ambulatory patient cohort. Circ Arrhythm Electrophysiol. 2017;10 - PubMed
    1. Swenson D.J., Taepke R.T., Blauer J.J.E. Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling. Heart Rhythm. 2020;17:1602–1608. - PubMed